Allworth Financial LP grew its stake in MetLife, Inc. (NYSE:MET - Free Report) by 114.3% in the fourth quarter, according to the company in its most recent filing with the Securities and Exchange Commission (SEC). The fund owned 10,276 shares of the financial services provider's stock after acquiring an additional 5,481 shares during the quarter. Allworth Financial LP's holdings in MetLife were worth $881,000 at the end of the most recent quarter.
A number of other institutional investors and hedge funds also recently modified their holdings of the stock. United Asset Strategies Inc. increased its stake in shares of MetLife by 1.1% in the 4th quarter. United Asset Strategies Inc. now owns 10,933 shares of the financial services provider's stock valued at $895,000 after acquiring an additional 120 shares during the last quarter. Barrett & Company Inc. increased its stake in MetLife by 1.0% during the 4th quarter. Barrett & Company Inc. now owns 11,942 shares of the financial services provider's stock worth $978,000 after purchasing an additional 121 shares in the last quarter. Great Valley Advisor Group Inc. increased its stake in MetLife by 1.3% during the 3rd quarter. Great Valley Advisor Group Inc. now owns 9,464 shares of the financial services provider's stock worth $781,000 after purchasing an additional 123 shares in the last quarter. First Commonwealth Financial Corp PA increased its stake in MetLife by 0.8% during the 3rd quarter. First Commonwealth Financial Corp PA now owns 16,675 shares of the financial services provider's stock worth $1,375,000 after purchasing an additional 133 shares in the last quarter. Finally, Avestar Capital LLC increased its stake in MetLife by 3.2% during the 3rd quarter. Avestar Capital LLC now owns 4,264 shares of the financial services provider's stock worth $352,000 after purchasing an additional 133 shares in the last quarter. 94.99% of the stock is owned by institutional investors.
Analyst Upgrades and Downgrades
A number of research firms recently issued reports on MET. Keefe, Bruyette & Woods lowered their target price on MetLife from $100.00 to $98.00 and set an "outperform" rating for the company in a research note on Wednesday, February 12th. JPMorgan Chase & Co. increased their target price on MetLife from $86.00 to $88.00 and gave the stock an "overweight" rating in a research note on Tuesday, January 7th. StockNews.com cut MetLife from a "buy" rating to a "hold" rating in a research note on Thursday, January 9th. Wells Fargo & Company upped their price target on MetLife from $92.00 to $97.00 and gave the stock an "overweight" rating in a research report on Wednesday. Finally, Barclays reduced their price target on MetLife from $96.00 to $95.00 and set an "overweight" rating for the company in a research report on Friday, February 7th. Two equities research analysts have rated the stock with a hold rating and eleven have issued a buy rating to the company's stock. According to data from MarketBeat.com, the stock has a consensus rating of "Moderate Buy" and an average price target of $92.58.
View Our Latest Analysis on MET
MetLife Stock Down 2.1 %
Shares of NYSE MET traded down $1.73 during trading hours on Friday, hitting $81.02. The company had a trading volume of 3,282,193 shares, compared to its average volume of 3,504,177. The stock has a market capitalization of $56.10 billion, a P/E ratio of 13.57, a price-to-earnings-growth ratio of 0.65 and a beta of 1.07. The company has a quick ratio of 0.16, a current ratio of 0.16 and a debt-to-equity ratio of 0.54. MetLife, Inc. has a 1-year low of $67.30 and a 1-year high of $89.05. The firm's 50 day moving average is $83.41 and its 200-day moving average is $81.44.
MetLife (NYSE:MET - Get Free Report) last released its quarterly earnings data on Wednesday, February 5th. The financial services provider reported $2.08 EPS for the quarter, missing the consensus estimate of $2.13 by ($0.05). MetLife had a net margin of 6.19% and a return on equity of 20.42%. On average, analysts expect that MetLife, Inc. will post 9.65 earnings per share for the current fiscal year.
MetLife Dividend Announcement
The business also recently disclosed a quarterly dividend, which will be paid on Tuesday, March 11th. Stockholders of record on Tuesday, February 4th will be issued a $0.545 dividend. This represents a $2.18 annualized dividend and a dividend yield of 2.69%. The ex-dividend date is Tuesday, February 4th. MetLife's payout ratio is presently 36.52%.
MetLife Profile
(
Free Report)
MetLife, Inc, a financial services company, provides insurance, annuities, employee benefits, and asset management services worldwide. It operates through six segments: Retirement and Income Solutions; Group Benefits; Asia; Latin America; Europe, the Middle East and Africa; and MetLife Holdings. The company offers life, dental, group short-and long-term disability, individual disability, pet insurance, accidental death and dismemberment, vision, and accident and health coverages, as well as prepaid legal plans; administrative services-only arrangements to employers; and general and separate account, and synthetic guaranteed interest contracts, as well as private floating rate funding agreements.
Further Reading

Before you consider MetLife, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and MetLife wasn't on the list.
While MetLife currently has a Moderate Buy rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Enter your email address and we'll send you MarketBeat's guide to investing in 5G and which 5G stocks show the most promise.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.